rs748152539
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_012123.4(MTO1):c.1450C>T(p.Arg484Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R484Q) has been classified as Pathogenic.
Frequency
Consequence
NM_012123.4 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiencyInheritance: AR, Unknown Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MTO1 | NM_012123.4 | c.1450C>T | p.Arg484Trp | missense_variant | Exon 8 of 12 | ENST00000498286.6 | NP_036255.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MTO1 | ENST00000498286.6 | c.1450C>T | p.Arg484Trp | missense_variant | Exon 8 of 12 | 1 | NM_012123.4 | ENSP00000419561.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152038Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251430 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000588 AC: 86AN: 1461854Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152038Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74268 show subpopulations
ClinVar
Submissions by phenotype
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency Pathogenic:4
- -
- -
- -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 484 of the MTO1 protein (p.Arg484Trp). This variant is present in population databases (rs748152539, gnomAD 0.004%). This missense change has been observed in individual(s) with combined oxidative phosphorylation deficiency 10 (PMID: 29331171, 30831263, 31451716, 31842146). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 408272). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MTO1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30831263, 29331171, 33258288, Almeida2023_Article, 31451716, 31842146, 38465286) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at